How to Manage Drug Interactions in Clinical Settings (1)

DOI Web Site 1 Citations 9 References Open Access
  • Ohno Yoshiyuki
    The First Academic Subcommittee of Japanese Society of Pharmaceutical Health Care and Sciences Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo
  • Hisaka Akihiro
    The First Academic Subcommittee of Japanese Society of Pharmaceutical Health Care and Sciences Laboratory of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University
  • Iwamoto Takuya
    The First Academic Subcommittee of Japanese Society of Pharmaceutical Health Care and Sciences Department of Pharmacy, Mie University Hospital, Faculty of Medicine, Mie University
  • Kimura Takeshi
    The First Academic Subcommittee of Japanese Society of Pharmaceutical Health Care and Sciences Department of Pharmacy, Kobe University Hospital
  • Momo Kenji
    The First Academic Subcommittee of Japanese Society of Pharmaceutical Health Care and Sciences Department of Pharmacy, The Institute of Medical Science Hospital, The University of Tokyo
  • Yonezawa Atsushi
    The First Academic Subcommittee of Japanese Society of Pharmaceutical Health Care and Sciences Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital
  • Ito Kiyomi
    The First Academic Subcommittee of Japanese Society of Pharmaceutical Health Care and Sciences Research Institute of Pharmaceutical Sciences, Musashino University

Bibliographic Information

Other Title
  • 医療現場における薬物相互作用へのかかわり方（1）
  • New Guideline and Management in Clinical Settings
  • 新しいガイドラインと医療現場でのマネジメント

Search this article

Description

<p>The first academic subcommittee of the Japanese Society of Pharmaceutical Health Care and Sciences has a plan to create a guide on how to manage drug interactions in clinical settings. This review describes the information that forms the basis of the guide. This article, part (1), reports the results of a questionnaire on the content of the guide and also describes how to evaluate and manage drug interactions in clinical settings. The contents of the ʻDrug Interaction Guideline for Drug Development and Labeling Recommendationsʼ, the new Japanese guideline, are also described. It is important also in clinical practice to appropriately evaluate and manage drug interactions based on a sufficient understanding of the new guideline and related information.</p>

Journal

Citations (1)*help

See more

References(9)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top